Hosted on MSN1h
Cantor Fitzgerald Initiates Coverage of Domo (DOMO) with Overweight Recommendation
Fintel reports that on February 11, 2025, Cantor Fitzgerald initiated coverage of Domo (NasdaqGM:DOMO) with a Overweight ...
‘We think the Mag7 are vulnerable’ - Cantor Fitzgerald
Cantor Fitzgerald came out and expressed concerns around the Magnificent Seven group, saying the stocks are “vulnerable.” ...
Cantor Fitzgerald maintains Ascendis Pharma Overweight rating
Cantor Fitzgerald reaffirmed its Overweight rating and $170.00 price target on Ascendis Pharma (NASDAQ:ASND) shares, currently trading at $119.49. The firm's analyst highlighted the early adoption of ...
New York Magazine18h
Trump Cabinet Confirmation Hearings: Schedule & How to Watch
Will the Senate GOP confirm controversial picks like Tulsi Gabbard and RFK Jr.? Here’s the hearings schedule and list of ...
Scotiabank Reaffirms Their Buy Rating on AST SpaceMobile (ASTS)
In a report released today, Andres Coello from Scotiabank maintained a Buy rating on AST SpaceMobile (ASTS – Research Report), with a price ...